![Scott Reents](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Reents
Finanzdirektor/CFO bei
TOBIRA THERAPEUTICS INC
Vermögen: 10 Mio $ am 31.07.2026
Profil
Scott T.
Reents currently serves as President & Director at Allergan, Inc., Celsius Therapeutics, Inc., Oculeve, Inc., and Allergan GI Corp.
He is Chief Financial Officer & Executive Vice President at AbbVie, Inc. since 2022, Chief Financial Officer at Tobira Therapeutics, Inc., Manager at Pharmacyclics LLC, and President at Landos Biopharma, Inc. Formerly, Mr. Reents was President & Director at Cerevel Therapeutics Holdings, Inc. and Vice President-Tax at Abbott Laboratories.
Education includes undergraduate studies at the University of Nebraska and graduate studies including an MBA at the University of Washington.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABBVIE, INC. 0 % | 06.03.2026 | 38.777 ( 0 % ) | 10 Mio $ | 31.07.2026 |
Aktive Positionen von Scott Reents
| Unternehmen | Position | Beginn |
|---|---|---|
| TOBIRA THERAPEUTICS INC | Finanzdirektor/CFO | - |
| ABBVIE INC. | Finanzdirektor/CFO | 23.06.2022 |
| ALLERGAN, INC. | Präsident | - |
| LANDOS BIOPHARMA, INC. | Präsident | - |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | Präsident | - |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Präsident | - |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Präsident | - |
Ehemalige bekannte Positionen von Scott Reents
| Unternehmen | Position | Ende |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Präsident | - |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Scott Reents
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
